Minireviews
Copyright ©The Author(s) 2016.
World J Gastrointest Oncol. May 15, 2016; 8(5): 450-458
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.450
Table 5 Burdens, harms, benefits, and efficiencies for fecal immunological technique and fecal occult blood testing at 3-year adherence rates compared to recommended intervals for colonoscopy and mt-sDNA, ages 50-75, per 1000 people screened
Burdens and harms
Benefits
CISNETmodelTestStool testsTotal COLComplicationsLYGCRC DACRC incidence reductionCRC mortality reduction% of COL 10y LYGCOL per LYGComplications per LYGComplications per DA
SimCRCCOL 10y04007142752481%87%100%150.0510.58
FIT3y688797162121845%65%77%50.0280.33
hsFOBT3y6456128672121847%66%77%60.0330.39
mt-sDNA3y5990170192502263%78%91%70.0360.41
MISCANCOL 10y04101152482262%79%100%170.0600.68
FIT3y679599571761528%55%71%60.0400.47
hsFOBT3y6302129681751530%55%71%70.0460.53
mt-sDNA3y5779171492151943%68%87%80.0420.49
CRC-SPINCOL 10y04049152702488%90%100%150.0560.62
FIT3y6857108171781649%59%66%60.0390.44
hsFOBT3y6498131781831653%61%68%70.0440.50
mt-sDNA3y59271827102262068%76%84%80.0440.50